Interpersonal Psychotherapy for Treatment Resistant Depression

NCT01896349 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2013-07-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether combination of antidepressant drugs plus interpersonal psychotherapy is superior to antidepressant drugs alone in treatment resistant depression.

Conditions

Interventions

OTHER

IPT+ antidepressant drugs

16 sessions of interpersonal psychotherapy plus antidepressant drugs.

DRUG

fluoxetine

Antidepressant drugs, clinician´s free choice oriented by guidelines. Monotherapy or combinations are allowed

DRUG

sertraline

DRUG

paroxetine

DRUG

Citalopram

DRUG

escitalopram

DRUG

fluvoxamine

DRUG

Venlafaxine

DRUG

Duloxetine

DRUG

Bupropion

DRUG

Lithium

DRUG

Risperidone

DRUG

tranylcypromine

DRUG

Imipramine

DRUG

amitriptyline

DRUG

Clomipramine

DRUG

nortriptyline

DRUG

trazodone

DRUG

Mirtazapine

DRUG

sulpiride

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Marcelo PA Fleck, MD,PhD · Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-08-31
Completion
2014-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01896349 on ClinicalTrials.gov